Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
6.90
+0.97 (16.36%)
Apr 20, 2026, 11:02 AM EDT - Market open
Edesa Biotech Market Cap
Edesa Biotech has a market cap or net worth of $61.31 million as of April 20, 2026. Its market cap has increased by 257.88% in one year.
Market Cap
61.31M
Enterprise Value
40.64M
1-Year Change
257.88%
Ranking
Category
Stock Price
$6.90
Market Cap Chart
Since June 10, 2019, Edesa Biotech's market cap has increased from $37.12M to $61.31M, an increase of 65.18%. That is a compound annual growth rate of 7.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 52.69M | 345.26% |
| Dec 31, 2025 | 11.83M | 103.14% |
| Dec 31, 2024 | 5.83M | -59.72% |
| Dec 29, 2023 | 14.46M | -65.40% |
| Dec 30, 2022 | 41.80M | -45.08% |
| Dec 31, 2021 | 76.11M | 70.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Metagenomi Therapeutics | 55.68M |
| Dogwood Therapeutics | 55.45M |
| Actuate Therapeutics | 54.77M |
| Kezar Life Sciences | 54.15M |
| Mereo BioPharma Group | 53.73M |
| Nutriband | 52.27M |
| Radiopharm Theranostics | 52.23M |
| Hyperion DeFi | 50.81M |